Bumepamine, a Brain-Permeant Benzylamine Derivative of Bumetanide, Does Not Inhibit NKCC1 but Is More Potent to Enhance Phenobarbital’s Anti-Seizure Efficacy
Neuropharmacology - United Kingdom
doi 10.1016/j.neuropharm.2018.09.025
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Elsevier BV